Samsung Biologics Co.,Ltd.
$774.27
24H
Market Cap
Volume
Supply
Price Chart
About Samsung Biologics Co.,Ltd. - 207940.KS
Samsung Biologics Co., Ltd. is a South Korean biopharmaceutical company specializing in biologic drug development and manufacturing, offering services from cell line generation to fill and finish. Established as a part of the Samsung conglomerate, the company leverages its large-scale production facilities to cater to the global pharmaceutical market.
What are Samsung Biologics Co.,Ltd.'s core values and mission statement?
Samsung Biologics' mission is to become a world-leading contract development and manufacturing organization (CDMO) by providing its clients with the highest quality and most reliable biopharmaceutical manufacturing services. Their core values focus on delivering excellence, creating value for customers, respecting life, and maintaining a commitment to continuous innovation and integrity in their work.
Who founded Samsung Biologics Co.,Ltd. and when?
Samsung Biologics Co., Ltd. was established by Samsung Group in April 2011.
Who leads Samsung Biologics Co.,Ltd.?
Samsung Biologics Co., Ltd., a major player in biopharmaceutical manufacturing, is led by its CEO John Rim, who holds the position at least since the last public information was available. However, for the most current leadership details, please consult the latest company reports or official announcements from Samsung Biologics.
Where is Samsung Biologics Co.,Ltd. located, and what is its base country?
Samsung Biologics Co., Ltd. is located in Incheon, South Korea, and its base country is South Korea.
On which exchanges is Samsung Biologics Co.,Ltd. traded?
Samsung Biologics Co., Ltd. is traded on the Korea Exchange (KRX) under the ticker symbol 207940.
Historical data
Samsung Biologics Co.,Ltd. (207940) Price Live Data
The live price of Samsung Biologics Co.,Ltd. (207940) is $774.27, with a trading volume of 114,696 in the last 24 hours. Wrapstocks updates the 207940 price in real-time. Samsung Biologics Co.,Ltd. is up 0.29% in the last 24 hours. The company has a live market cap of $55,108,033,616.81 and a supply of 71,173,998 207940 stocks.
Samsung Biologics Co.,Ltd. (207940) is traded on South Korea Stock Exchange, and currently, the market is closed; trading will be resumed in 3 hours and 23 minutes.